Bio-Rad Laboratories, Inc. (BIO)
USD 323.94
(-4.12%)
USD 323.94
(-4.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.67 Billion | 2.8 Billion | 2.92 Billion | 2.54 Billion | 2.31 Billion | 2.29 Billion |
| Cost of Revenue | 1.23 Billion | 1.23 Billion | 1.28 Billion | 1.1 Billion | 1.05 Billion | 1.06 Billion |
| Gross Profit | 1.43 Billion | 1.56 Billion | 1.64 Billion | 1.43 Billion | 1.25 Billion | 1.22 Billion |
| Operating Expenses | 1.04 Billion | 1.08 Billion | 1.15 Billion | 1.02 Billion | 1.02 Billion | 1.03 Billion |
| Selling, General and Administrative Expenses | 820.62 Million | 827.82 Million | 879.57 Million | 800.26 Million | 824.62 Million | 833.29 Million |
| Research and Development Expenses | 226.92 Million | 256.88 Million | 271.65 Million | 226.59 Million | 202.71 Million | 199.19 Million |
| Other Expenses | - | 44.57 Million | 26.77 Million | 24.48 Million | 26.09 Million | 36.59 Million |
| Cost and Expenses | 2.28 Billion | 2.31 Billion | 2.43 Billion | 2.13 Billion | 2.08 Billion | 2.09 Billion |
| Operating Income | 383.79 Million | 482.61 Million | 489.43 Million | 410.95 Million | 229.66 Million | -108.64 Million |
| Interest Expense | 49.43 Million | 38.11 Million | 1.55 Million | 21.86 Million | 23.41 Million | 23.96 Million |
| Income Tax Expense | -212.78 Million | -1.07 Billion | 1.19 Billion | 1.1 Billion | 502.4 Million | 146.36 Million |
| Earnings before Tax | -850.1 Million | -4.7 Billion | 5.43 Billion | 4.9 Billion | 2.26 Billion | 507.35 Million |
| Net Income | -637.32 Million | -3.62 Billion | 4.25 Billion | 3.81 Billion | 1.75 Billion | 360.99 Million |
| Earnings Per Share Basic | -21.82 | -121.79 | 142.61 | 127.86 | 58.93 | 12.10 |
| Earnings Per Share Diluted | -21.82 | -121.79 | 140.83 | 126.20 | 58.27 | 11.94 |
| Weighted Average Shares Outstanding | 29.2 Million | 29.78 Million | 29.83 Million | 29.76 Million | 29.84 Million | 29.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.2 Million | 29.78 Million | 30.2 Million | 30.16 Million | 30.18 Million | 30.22 Million |
| Gross Margin | 0.54 | 0.56 | 0.56 | 0.56 | 0.54 | 0.53 |
| EBIT Margin | -0.23 | 0.24 | 0.22 | 0.23 | 0.17 | 0.16 |
| Profit Margin | -0.24 | -1.29 | 1.46 | 1.50 | 0.76 | 0.16 |
| EBITDA | -608.26 Million | -4.48 Billion | 5.62 Billion | 5.1 Billion | 2.45 Billion | 674.72 Million |
| Earnings Before Tax Margin | 0.14 | 0.17 | 0.17 | 0.16 | 0.10 | -0.05 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 649.72 Million | 638.47 Million | 610.82 Million | 681.18 Million | 2.67 Billion | 632.12 Million |
| Cost of Revenue | 294.92 Million | 282.75 Million | 284.35 Million | 315.28 Million | 1.23 Billion | 296.44 Million |
| Gross Profit | 354.8 Million | 355.71 Million | 326.46 Million | 365.9 Million | 1.43 Billion | 335.68 Million |
| Operating Expenses | 296.43 Million | 255.42 Million | 274.45 Million | 268.1 Million | 1.04 Billion | 244.73 Million |
| Selling, General and Administrative Expenses | 203.44 Million | 196.11 Million | 210.48 Million | 205.89 Million | - | 201.19 Million |
| Research and Development Expenses | 92.99 Million | 59.3 Million | 63.97 Million | 62.21 Million | - | 43.53 Million |
| Other Expenses | -2.3 Million | 1.6 Million | 700 Thousand | -65 Thousand | 2.3 Million | 20.44 Million |
| Cost and Expenses | 591.36 Million | 538.18 Million | 558.81 Million | 583.39 Million | 2.28 Billion | 541.17 Million |
| Operating Income | 58.36 Million | 100.29 Million | 52 Million | 97.79 Million | 383.79 Million | 90.94 Million |
| Interest Expense | 12.17 Million | 12.26 Million | 12.27 Million | 12.36 Million | 49.43 Million | 12.39 Million |
| Income Tax Expense | 818.81 Million | -620.79 Million | 107.16 Million | 78.68 Million | -212.78 Million | 30.84 Million |
| Earnings before Tax | 861.62 Million | -2.78 Billion | 491.07 Million | 428.39 Million | -850.1 Million | 137.1 Million |
| Net Income | 653.17 Million | -2.16 Billion | 383.91 Million | 349.7 Million | -637.32 Million | 106.25 Million |
| Earnings Per Share Basic | 23.09 | -76.26 | 13.46 | 12.15 | - | 3.65 |
| Earnings Per Share Diluted | 23.09 | -76.26 | 13.45 | 12.14 | - | 3.64 |
| Weighted Average Shares Outstanding | 28.28 Million | 28.39 Million | 28.51 Million | 28.79 Million | 29.2 Million | 29.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.28 Million | 28.39 Million | 28.53 Million | 28.81 Million | 29.2 Million | 29.22 Million |
| Gross Margin | 0.55 | 0.56 | 0.53 | 0.54 | 0.54 | 0.53 |
| EBIT Margin | 2.14 | 0.23 | 0.16 | 0.22 | - | 0.24 |
| Profit Margin | 1.01 | -3.39 | 0.63 | 0.51 | -0.24 | 0.17 |
| EBITDA | 1.38 Billion | 146.89 Million | 99.8 Million | 150.79 Million | - | 148.71 Million |
| Earnings Before Tax Margin | 0.09 | 0.16 | 0.09 | 0.14 | 0.14 | 0.14 |
BENGALASM
ZRSEF
BCU
TRT
TRI
BKT